Literature DB >> 10954521

Evolution of swine H3N2 influenza viruses in the United States.

R J Webby1, S L Swenson, S L Krauss, P J Gerrish, S M Goyal, R G Webster.   

Abstract

During 1998, severe outbreaks of influenza were observed in four swine herds in the United States. This event was unique because the causative agents, H3N2 influenza viruses, are infrequently isolated from swine in North America. Two antigenically distinct reassortant viruses (H3N2) were isolated from infected animals: a double-reassortant virus containing genes similar to those of human and swine viruses, and a triple-reassortant virus containing genes similar to those of human, swine, and avian influenza viruses (N. N. Zhou, D. A. Senne, J. S. Landgraf, S. L. Swenson, G. Erickson, K. Rossow, L. Liu, K.-J. Yoon, S. Krauss, and R. G. Webster, J. Virol. 73:8851-8856, 1999). Because the U.S. pig population was essentially naive in regard to H3N2 viruses, it was important to determine the extent of viral spread. Hemagglutination inhibition (HI) assays of 4, 382 serum samples from swine in 23 states indicated that 28.3% of these animals had been exposed to classical swine-like H1N1 viruses and 20.5% had been exposed to the triple-reassortant-like H3N2 viruses. The HI data suggested that viruses antigenically related to the double-reassortant H3N2 virus have not become widespread in the U.S. swine population. The seroreactivity levels in swine serum samples and the nucleotide sequences of six additional 1999 isolates, all of which were of the triple-reassortant genotype, suggested that H3N2 viruses containing avian PA and PB2 genes had spread throughout much of the country. These avian-like genes cluster with genes from North American avian viruses. The worldwide predominance of swine viruses containing an avian-like internal gene component suggests that these genes may confer a selective advantage in pigs. Analysis of the 1999 swine H3N2 isolates showed that the internal gene complex of the triple-reassortant viruses was associated with three recent phylogenetically distinct human-like hemagglutinin (HA) molecules. Acquisition of HA genes from the human virus reservoir will significantly affect the efficacy of the current swine H3N2 vaccines. This finding supports continued surveillance of U.S. swine populations for influenza virus activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954521      PMCID: PMC116332          DOI: 10.1128/jvi.74.18.8243-8251.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Update: influenza activity--United States and worldwide, 1996-97 season, and composition of the 1997-98 influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-04-18       Impact factor: 17.586

2.  Continued evolution of H1N1 and H3N2 influenza viruses in pigs in Italy.

Authors:  L Campitelli; I Donatelli; E Foni; M R Castrucci; C Fabiani; Y Kawaoka; S Krauss; R G Webster
Journal:  Virology       Date:  1997-06-09       Impact factor: 3.616

3.  Initial genetic characterization of the 1918 "Spanish" influenza virus.

Authors:  J K Taubenberger; A H Reid; A E Krafft; K E Bijwaard; T G Fanning
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

4.  Transmission of swine influenza virus to humans after exposure to experimentally infected pigs.

Authors:  D E Wentworth; M W McGregor; M D Macklin; V Neumann; V S Hinshaw
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

5.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.

Authors:  K Subbarao; A Klimov; J Katz; H Regnery; W Lim; H Hall; M Perdue; D Swayne; C Bender; J Huang; M Hemphill; T Rowe; M Shaw; X Xu; K Fukuda; N Cox
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

6.  Persistence of a 1930 swine influenza A (H1N1) virus in Quebec.

Authors:  M H Bikour; E H Frost; S Deslandes; B Talbot; Y Elazhary
Journal:  J Gen Virol       Date:  1995-10       Impact factor: 3.891

7.  Infection of children with avian-human reassortant influenza virus from pigs in Europe.

Authors:  E C Claas; Y Kawaoka; J C de Jong; N Masurel; R G Webster
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

8.  Genetic analysis of porcine H3N2 viruses originating in southern China.

Authors:  K Nerome; Y Kanegae; K F Shortridge; S Sugita; M Ishida
Journal:  J Gen Virol       Date:  1995-03       Impact factor: 3.891

9.  Potential for transmission of avian influenza viruses to pigs.

Authors:  H Kida; T Ito; J Yasuda; Y Shimizu; C Itakura; K F Shortridge; Y Kawaoka; R G Webster
Journal:  J Gen Virol       Date:  1994-09       Impact factor: 3.891

Review 10.  Influenza: interspecies transmission and emergence of new pandemics.

Authors:  R G Webster; K F Shortridge; Y Kawaoka
Journal:  FEMS Immunol Med Microbiol       Date:  1997-08
View more
  143 in total

Review 1.  Influenza: emergence and control.

Authors:  Aleksandr S Lipatov; Elena A Govorkova; Richard J Webby; Hiroichi Ozaki; Malik Peiris; Yi Guan; Leo Poon; Robert G Webster
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  Combination of PB2 271A and SR polymorphism at positions 590/591 is critical for viral replication and virulence of swine influenza virus in cultured cells and in vivo.

Authors:  Qinfang Liu; Chuanling Qiao; Henju Marjuki; Bhupinder Bawa; Jingqun Ma; Stephane Guillossou; Richard J Webby; Jürgen A Richt; Wenjun Ma
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Aerosol Transmission from Infected Swine to Ferrets of an H3N2 Virus Collected from an Agricultural Fair and Associated with Human Variant Infections.

Authors:  Bryan S Kaplan; J Brian Kimble; Jennifer Chang; Tavis K Anderson; Phillip C Gauger; Alicia Janas-Martindale; Mary Lea Killian; Andrew S Bowman; Amy L Vincent
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

4.  Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.

Authors:  Jürgen A Richt; Porntippa Lekcharoensuk; Kelly M Lager; Amy L Vincent; Christina M Loiacono; Bruce H Janke; Wai-Hong Wu; Kyoung-Jin Yoon; Richard J Webby; Alicia Solórzano; Adolfo García-Sastre
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

5.  Are swine workers in the United States at increased risk of infection with zoonotic influenza virus?

Authors:  Kendall P Myers; Christopher W Olsen; Sharon F Setterquist; Ana W Capuano; Kelley J Donham; Eileen L Thacker; James A Merchant; Gregory C Gray
Journal:  Clin Infect Dis       Date:  2005-11-22       Impact factor: 9.079

Review 6.  Animal influenza epidemiology.

Authors:  M F Ducatez; R G Webster; R J Webby
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

7.  Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in U.S. swine.

Authors:  Nicola S Lewis; Tavis K Anderson; Pravina Kitikoon; Eugene Skepner; David F Burke; Amy L Vincent
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  Comparison of the pathogenesis of two genetically different H3N2 influenza A viruses in pigs.

Authors:  Gabriele A Landolt; Alexander I Karasin; Lynette Phillips; Christopher W Olsen
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States.

Authors:  Jürgen A Richt; Kelly M Lager; Bruce H Janke; Roger D Woods; Robert G Webster; Richard J Webby
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.

Authors:  Gavin J D Smith; Dhanasekaran Vijaykrishna; Justin Bahl; Samantha J Lycett; Michael Worobey; Oliver G Pybus; Siu Kit Ma; Chung Lam Cheung; Jayna Raghwani; Samir Bhatt; J S Malik Peiris; Yi Guan; Andrew Rambaut
Journal:  Nature       Date:  2009-06-25       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.